首页 › 基金 › SymBiosis Capital Partners, LLC › WVE

SymBiosis Capital Partners, LLC 对 WVE 的持仓历史

WAVE LIFE SCIENCES INC · 医疗保健

SymBiosis Capital Partners, LLC 在 Q1 2026 的 13F 申报中披露持有 WVE(WAVE LIFE SCIENCES INC)750,000 股,市值约 US$5.4M,约占其申报组合的 10.30%,在其申报持仓中市值排名第 3 位。 SymBiosis Capital Partners, LLC 于 Q1 2026 首次申报该持仓。

最新持仓 (Q1 2026)750.00K 股
申报持仓市值$5.44M
组合权重10.30%
首次申报Q1 2026
最近变动新进
更新于2026-10-18

最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR

SymBiosis Capital Partners, LLC 对 WVE 的持仓演变

SymBiosis Capital Partners, LLC 于 Q1 2026 首次披露 WVE 持仓:750,000 股(约 US$5.4M)。

逐季持仓明细

季度股数金额变化
Q1 2026 750.00K $5.44M 新进

关于 WVE 与 13F 数据

WVE(WAVE LIFE SCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 WVE,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$156.7M), GSK plc (US$106.0M), Maverick 资本 (US$59.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 WVE 的基金

查看 WVE 的全部基金持有人 →

常见问题

How long has SymBiosis Capital Partners, LLC held WVE?

SymBiosis Capital Partners, LLC has disclosed WVE holdings in 1 of the last 1 reported quarters, going back to Q1 2026.

What is SymBiosis Capital Partners, LLC's current position in WVE?

As of Q1 2026, SymBiosis Capital Partners, LLC holds 750.00K shares of WVE (WAVE LIFE SCIENCES INC), valued at $5.44M, representing 10.30% of its reported portfolio and ranking #3.

Has SymBiosis Capital Partners, LLC been buying or selling WVE?

In the latest 13F filing (Q1 2026), SymBiosis Capital Partners, LLC newly opened its position in WVE.

Which other funds hold WVE?

Other major institutional holders of WVE include RA CAPITAL MANAGEMENT, L.P., GSK plc, Maverick 资本, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.